Pfizer acquires stem cell therapies assets of Axordia - MarketLine Financial Deals

Pfizer acquires stem cell therapies assets of Axordia

Pfizer acquires stem cell therapies assets of Axordia - MarketLine Financial Deals
Pfizer acquires stem cell therapies assets of Axordia
Published Nov 23, 2009
2 pages — Published Nov 23, 2009
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Pfizer, Ltd., a pharmaceutical company, has acquired certain assets related to stem cell therapies from Axordia Limited, a developer of stem cell therapies for human diseases.

  
Source:
Document ID
MA13389_091124
Country
Country
Ticker
ICX=GB
Ticker
PFE=US
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Pfizer acquires stem cell therapies assets of Axordia" Nov 23, 2009. Alacra Store. Dec 10, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Pfizer-acquires-stem-cell-therapies-assets-of-Axordia-2052-18231>
  
APA:
MarketLine Financial Deals. (2009). Pfizer acquires stem cell therapies assets of Axordia Nov 23, 2009. New York, NY: Alacra Store. Retrieved Dec 10, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Pfizer-acquires-stem-cell-therapies-assets-of-Axordia-2052-18231>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.